Navigation Links
Will Lipodissolve Continue to Remain Popular?
Date:12/12/2007

Leading Dermatologist Doing His Part to Warn Consumers

OMAHA, Neb., Dec. 12 /PRNewswire/ -- Lipodissolve, a treatment for unwanted fat, has been in the news for the past several years with significant controversy about its effectiveness and safety. Now, Fig, the parent company for up to 18 facilities around the country that offer this treatment and defender of this procedure, has closed its stores and is considering declaring bankruptcy. This is in addition to a longtime 'unsatisfactory' rating by the St. Louis Better Business Bureau, with 102 complaints over a year's period.

Despite the closure of this company, there are many companies still selling the non FDA approved substance, PC/DC, which is used for this procedure. Joel Schlessinger, M.D., Board-Certified Dermatologist and Board-Certified General Cosmetic Surgeon and immediate past-president of the American Society of Cosmetic Dermatology and Aesthetic Surgery (ASCDAS), has been involved in spotlighting the dangers of treatment. He is also involved in efforts to stop this treatment from being performed in his state, Nebraska. Just Monday, December 10th, Kansas enacted stricter restrictions on this procedure.

"It doesn't surprise me that Fig closed down -- the handwriting was on the wall when they received the unsatisfactory rating from the BBB. While I've been working on the Lipodissolve issue, many people have sustained harm from this unapproved procedure. Now, countless people have lost their money without any recourse due to the financial uncertainty of this company," says Schlessinger.

"Patient safety shouldn't be put in jeopardy for the sake of making a profit," said Joel Schlessinger M.D., founder of LovelySkin.com. "I've seen half a dozen cases of patients who received treatments and then had pain, swelling, bruising, bloating in the treatment areas, irregular dimpling and divots in the skin. Hopefully, this closure will stop some of this from happening."

Dr. Schlessinger is available for comment on Lipodissolve and its lack of safety. Interviews with Dr. Schlessinger are available and interested media may contact the company at 772-633-8337.

About Dr. Schlessinger

Joel Schlessinger M.D., board-certified dermatologist and general cosmetic surgeon, is the immediate past-president of ASCDAS and the Nebraska Dermatology Society. He continues to work with the FDA and the Nebraska State Board of Healing Arts to regulate Lipodissolve.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Joel Schlessinger, MD http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=35185


'/>"/>
SOURCE Joel Schlessinger M.D.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Lipodissolve - Is it Safe???
2. Battle Continues Over Vietnam PTSD Numbers
3. Continued Statin Use Boosts Post-Stroke Outcomes
4. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
5. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
6. Securians Minnesota Life Continues to Climb Group Life Rankings
7. USA TODAY Continues Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
8. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
9. United States continues to have highest level of health spending
10. LehmanMillet Continues Expansion with Strategic Hires
11. Pink Ribbon Bagels Continue the Fight for a Cure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve ... engagement.” The patient is doing more than filling out a survey; in many cases ... an increasing emphasis in health care and research on the importance of active engagement ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology: